SNOW stock benefits from strong AI partnerships and portfolio expansion, but a stretched valuation raises caution.
A reduction in HIV incidence is possible with more structured choices for pre-exposure and postexposure prophylaxis being offered to patients at risk of HIV.
allAfrica.com on MSN
South Africa: Thousands of Kids With HIV Switched to Newer Treatment
A child-friendly formulation of the antiretroviral drug dolutegravir was first included in the country's HIV treatment guidelines in 2023. New estimates suggest that most children aged one to four ...
Breaking stock news is now free. Create your account to stay informed—and explore the insights behind every move.
Zacks Investment Research on MSN
Can Credo Sustain Momentum in Optical Business Amid Competition?
Credo Technology Group Holding Ltd’s CRDO is witnessing rapid momentum in its optical business, with management projecting that revenues from this business will double once again in fiscal 2026. The ...
In a nutshell The semiconductor manufacturing equipment market is now a vital cornerstone of global innovation and economic ...
Rapid release testing detects mycoplasma DNA with great sensitivity by using advanced technologies such nucleic acid ...
A new role for extracellular matrix remodelling in Rheumatoid Arthritis (RA) pathology has been discovered. Dynamic collagen ...
Alarum’s Q2 results show a slight revenue dip, but strong AI/ML demand and new contracts suggest future growth. Read here for ...
To evaluate Tau PFFs' neuroinflammatory and oxidative effects, cytokine expression and antioxidant responses were measured in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results